A Stanford research team that recently discovered an unexpected new chemical behavior of water when tiny droplets form from water vapor has extended the findings to natural, everyday water condensation. […]
The new capital and expertise will accelerate the development of Mekonos’ System on a Chip (SoC) and expand commercial partnerships
SAN FRANCISCO, Nov. 23, 2020 /PRNewswire/ — Mekonos, a biotech company launching the first-of-its kind system-on-a-ch… […]
The City of Vacaville, which last month unveiled plans for a next generation of biomanufacturing development, has put in place a new program designed to lure more biotech projects to Solano County.
The policy — unanimously endorsed last week by the Va… […]
Teneobio may be best known for its pact with AbbVie and Gilead, but before its big break the bispecific player had licensed its antibodies for a different use: as binders in CAR-T therapies being developed by Poseida.
Now, the biotechs ar… […]
Amgen is shrugging off a 14-year development alliance and the tens of millions of dollars spent to develop a new heart drug at Cytokinetics after a Phase III trial turned up weak data — leaving Cytokinetics to soldier on alone.
Omecamtiv mecarbil techn… […]
LEHI, Utah & SAN FRANCISCO–(BUSINESS WIRE)–To help Americans feel more connected, even when they may be apart this holiday season, Ancestry®, the global leader in family history, is offering everyone free access to personalized stories from Thank… […]
Back in the summer of 2019, Carl Hansen left his post as a professor at the University of British Columbia to go full time as the CEO at a low-profile antibody shop he had founded called AbCellera.
As biotech CEOs go, even after a fundraise Hansen wasn… […]
The partnership will expand Pharmavite’s evidence-based research and development pipeline for new product innovations
SAN FRANCISCO, Nov. 23, 2020 /PRNewswire/ — Brightseed, developer of Forager® AI, and Pharmavite LLC, a leader in the health and we… […]
SAN JOSE, Calif., Nov. 23, 2020 /PRNewswire/ — Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that an IND (Investigational New Drug) applica… […]
– Eiger and The Progeria Research Foundation will share proceeds 50/50- Non-dilutive capital further strengthens Eiger’s balance sheet
PALO ALTO, Calif., Nov. 23, 2020 /PRNewswire/ — Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the deve… […]